These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization. Cooke CE; Lee HY; Tong YP; Haines ST Curr Med Res Opin; 2010 Jan; 26(1):231-8. PubMed ID: 19921965 [TBL] [Abstract][Full Text] [Related]
4. Adherence to oral antidiabetic agents with pioglitazone and metformin: comparison of fixed-dose combination therapy with monotherapy and loose-dose combination therapy. Barner JC Clin Ther; 2011 Sep; 33(9):1281-8. PubMed ID: 21840054 [TBL] [Abstract][Full Text] [Related]
5. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis. Adeyemi AO; Rascati KL; Lawson KA; Strassels SA Clin Ther; 2012 Mar; 34(3):712-9. PubMed ID: 22381712 [TBL] [Abstract][Full Text] [Related]
6. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients. Cheong C; Barner JC; Lawson KA; Johnsrud MT Clin Ther; 2008 Oct; 30(10):1893-907. PubMed ID: 19014846 [TBL] [Abstract][Full Text] [Related]
7. Nonadherence as a predictor of antidiabetic drug therapy intensification (augmentation). Kogut SJ; Andrade SE; Willey C; Larrat EP Pharmacoepidemiol Drug Saf; 2004 Sep; 13(9):591-8. PubMed ID: 15362081 [TBL] [Abstract][Full Text] [Related]
8. The risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy. Johannes CB; Koro CE; Quinn SG; Cutone JA; Seeger JD Pharmacoepidemiol Drug Saf; 2007 May; 16(5):504-12. PubMed ID: 17245800 [TBL] [Abstract][Full Text] [Related]
9. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Hertz RP; Unger AN; Lustik MB Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485 [TBL] [Abstract][Full Text] [Related]
10. Race, ethnicity, and use of thiazolidinediones among US adults with diabetes. Aquilante CL; Zhang W; McCollum M Curr Med Res Opin; 2007 Mar; 23(3):489-94. PubMed ID: 17355730 [TBL] [Abstract][Full Text] [Related]
11. A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005. Hansen RA; Farley JF; Droege M; Maciejewski ML Clin Ther; 2010 Jul; 32(7):1308-19. PubMed ID: 20678679 [TBL] [Abstract][Full Text] [Related]
12. The association between adherence to oral anti-diabetic drugs and hypoglycaemia in persons with Type 2 diabetes. Quilliam BJ; Ozbay AB; Sill BE; Kogut SJ Diabet Med; 2013 Nov; 30(11):1305-13. PubMed ID: 23586474 [TBL] [Abstract][Full Text] [Related]
13. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid. Oladapo AO; Barner JC; Rascati KL; Strassels SA Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828 [TBL] [Abstract][Full Text] [Related]
14. Interrogation of a longitudinal, national pharmacy claims dataset to explore factors that predict the need for add-on therapy in older and socioeconomically disadvantaged Australians with type 2 diabetes mellitus patients (T2DM). Kumar SS; McManus H; Radovich T; Greenfield JR; Viardot A; Williams KM; Cronin P; Day RO Eur J Clin Pharmacol; 2018 Oct; 74(10):1327-1332. PubMed ID: 29938343 [TBL] [Abstract][Full Text] [Related]
15. Discontinuation of statins among patients with type 2 diabetes. Lamberts EJ; Nijpels G; Welschen LM; Hugtenburg JG; Dekker JM; Souverein PC; Bouvy ML Diabetes Metab Res Rev; 2012 Mar; 28(3):241-5. PubMed ID: 21898755 [TBL] [Abstract][Full Text] [Related]
16. The relationship of guideline-concordant depression treatment and patient adherence to oral diabetes medications. Nau DP; Chao J; Aikens JE Res Social Adm Pharm; 2005 Sep; 1(3):378-88. PubMed ID: 17138485 [TBL] [Abstract][Full Text] [Related]
17. Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants. Caughey GE; Roughead EE; Shakib S; McDermott RA; Vitry AI; Gilbert AL Age Ageing; 2010 Jul; 39(4):488-94. PubMed ID: 20511245 [TBL] [Abstract][Full Text] [Related]
18. Medication use and potentially high-risk prescribing in older patients hospitalized for diabetes: a missed opportunity to improve care? Caughey GE; Barratt JD; Shakib S; Kemp-Casey A; Roughead EE Diabet Med; 2017 Mar; 34(3):432-439. PubMed ID: 27135418 [TBL] [Abstract][Full Text] [Related]
19. Anticholinesterase duration in the Australian veteran population. Gadzhanova S; Roughead L; Mackson J Aust N Z J Psychiatry; 2010 May; 44(5):469-74. PubMed ID: 20397790 [TBL] [Abstract][Full Text] [Related]
20. Impact of oral antihyperglycemic therapy on all-cause mortality among patients with diabetes in the Veterans Health Administration. Kahler KH; Rajan M; Rhoads GG; Safford MM; Demissie K; Lu SE; Pogach LM Diabetes Care; 2007 Jul; 30(7):1689-93. PubMed ID: 17440170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]